Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1α, HIF2α, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma

Overview of attention for article published in Journal of Experimental & Clinical Cancer Research, August 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 1 news outlet

twitter: 4 X users

Citations

dimensions_citation: 47 Dimensions

Readers on

mendeley: 40 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 news story.

Kidney cancer biomarkers and targets for therapeutics: survivin (BIRC5), XIAP, MCL-1, HIF1alpha, HIF2alpha, NRF2, MDM2, MDM4, p53, KRAS and AKT in renal cell carcinoma - Docwire News

Doc Wire News, 13 Aug 2021

This article was originally published here J Exp Clin Cancer Res. 2021 Aug 12;40(1):254.

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.